Sign in

CIK 0000899923 · Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870494517
Phone
801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 4,398 shares (to pay taxes)
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 8,761 shares (to pay taxes)
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Insider Changes in Ownership
  10. 8-K Event Executive or director change
  11. 4 Grant or award President and CEO acquired 3,542 shares (grant or award)
  12. 4 Grant or award Chief Commerical Officer acquired 5,000 shares (grant or award)
  13. 4 Planned sale Director sold 15,000 shares at $4.46 ($66,843)
  14. 144 Insider Sale of Securities
  15. 4 Grant or award Director acquired 59,701 shares (grant or award)
  16. 4 Grant or award Director acquired 59,701 shares (grant or award)
  17. 4 Grant or award Director acquired 59,701 shares (grant or award)
  18. 4 Grant or award Director acquired 59,701 shares (grant or award)
  19. 4 Grant or award Director acquired 59,701 shares (grant or award)
  20. 4 Grant or award Director acquired 59,701 shares (grant or award)

Page 2 of 104 · 2,077 filings